IP Library Granted Patent US 10,689,658
Granted Patent B2
US 10,689,658 · App. 16/054,711 · Granted Jun 23, 2020

Nucleic acid encoding N-methylputrescine oxidase and uses thereof

Inventors: Jonathan E. Page (Saskatoon, CA); Enwu Liu (Saskatoon, CA)
Assignee: 22nd Century Limited, LLC
C12N15/8243A24B13/00A24B15/12C12N9/0022C12Y104/03006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,689,658
App. No.
16/054,711
Granted
Jun 23, 2020
Kind
B2
Abstract

The gene encoding N-methylputrescine oxidase (MPO) and constructs comprising such DNA are provided, including methods of regulating MPO expression independently or with other alkaloid biosynthesis genes to modulate alkaloid production in plants and host cells. MPO genes or fragments thereof are useful for reducing pyrrolidine or tropane alkaloid production in plants, for increasing pyrrolidine or tropane alkaloid production in plants, and for producing an MPO enzyme in host cells.

Claims (13)

1. A tobacco plant comprising plant cells into which one or more mutations are introduced into the region of SEQ ID NO: 1 or SEQ ID NO: 2 that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 3, wherein the plant exhibits reduced expression of a gene product encoded by SEQ ID NO: 1 or SEQ ID NO: 2 as compared to a control tobacco plant.

2. The tobacco plant of claim 1 , wherein the tobacco plant exhibits a reduced nicotine level as compared to a control tobacco plant.

3. Seeds from or a progeny plant of the tobacco plant of claim 1 , wherein the seeds or progeny plant comprise in their genomes the one or more mutations.

4. A tobacco product comprising the plant of claim 2 , and having a reduced level of nicotine as compared to a tobacco product produced from a control tobacco plant.

5. The tobacco product of claim 4 , wherein the product is selected from the group consisting of smoking cessation products, cigarettes, cigarette tobacco, cigars, cigar tobacco, pipe tobacco, chewing tobacco, snuf, snus, and lozenges.

6. A tobacco plant produced by a method comprising:

(a) mutagenizing a plurality of tobacco plant cells to comprise one or more mutations in the nucleotide sequence set forth in SEQ ID NO: 1 or SEQ ID NO: 2, thereby producing a plurality of mutagenized cells comprising the one or more mutations in the nucleotide sequence set forth in SEQ ID NO: 1 or SEQ ID NO: 2;

(b) screening plants generated from the mutagenized cells comprising the one or more mutations in the nucleotide sequence set forth in SEQ ID NO: 1 or SEQ ID NO: 2 for reduced expression of N-methylputrescine oxidase (MPO); and

(c) selecting one or more of the progeny comprising the one or more mutations in the nucleotide sequence set forth in SEQ ID NO: 1 or SEQ ID NO: 2, wherein the progeny has reduced MPO expression and reduced nicotine content as compared to a control tobacco plant,

thereby resulting in a tobacco plant having reduced MPO expression and reduced nicotine content as compared to a control tobacco plant.

7. A tobacco product produced from the tobacco plant of claim 6 , wherein:

(a) the tobacco product is selected from the group consisting of smoking cessation products, cigarettes, cigarette tobacco, cigars, cigar tobacco, pipe tobacco, chewing tobacco, snuf, snus, and lozenges, and

(b) the tobacco product comprises the mutagenized cells of claim 6 .

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 055657/0887 →